Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings



Jan Adams

“Our R&D organisation is the driving force behind our pipeline of highly innovative assets that will deliver towards our vision of a world free of pain.”

Jan Adams

Chief Scientific Officer, Grünenthal

Always driven to improve patients’ lives, Jan Adams has built up more than 15 years of experience in healthcare and biopharmaceuticals.

Jan significantly contributed to working out our concise therapeutic area strategy and led the design and implementation of a future-proof R&D operating model that can successfully execute our strategy – flexible and modality-agnostic while leveraging a strong global network.

Jan joined Grünenthal in July 2017 as Head Corporate Strategy and Portfolio Management, working at the interface between strategy, research, development and commercial. Prior to joining Grünenthal, he served in roles with increasing levels of responsibility at Novartis and Takeda, as well as within McKinsey & Company’s global Pharmaceutical and Medical Products practice.

Jan Adams at a glance

Nationality: German

Year of birth: 1977

Education:  Medical Doctor (MD) at Medical Schools in Kiel, Frankfurt and Sidney; Doctoral Thesis at Goethe University Frankfurt

Family status: Married, two children

Leisure time:  My 2 daughters, traveling, hiking

Career highlights

Since 2020: Member of the Corporate Executive Board and Chief Scientific Officer, Grünenthal

2019: Deputy/Acting Chief Scientific Officer, Grünenthal

2017 – 2019: Senior Vice President & Head Corporate Strategy and Portfolio Management, Grünenthal

2016-2017: Vice President & Head R&D Strategic Management and Planning, Takeda Pharmaceuticals Inc.

2008-2016: Associate Principal, McKinsey & Company

2005-2007: Project Leader Cardiovascular and Hemostaseology, Clinical Development and Medical Affairs, Novartis Pharma

2004 – 2005: Resident at Hannover Medical School (MHH)